Kinsetsu is delighted to be joining the Association of British HealthTech Industries (ABHI) US Accelerator 2023 cohort, with the aim to promote the strengths of UK HealthTech stateside.
A leading group from the world of health technology are taking part in this year’s cohort. Together they constitute a diverse mix of medical device, diagnostics and digital health businesses, several of which are long-standing members of the programme, along with a host of new entrants.
Together they will showcase the excellence of the UK’s HealthTech industry and highlight the strength of UK innovation – seeking to strengthen trade ties between the two regions.
Along with the 2023 cohort of innovators, Kinsetsu will be showcasing the ‘ktrack’ platform which digitises healthcare assets to optimise procurement and management, ultimately to drive efficiency.
Joanne O’Doherty, CEO said “Kinsetsu is delighted to be among the leading UK HealthTech innovators joining the ABHI trade US Accelerator in 2023. We look forward to forging relationships in the US Healthcare and HealthTech markets as well as understanding the problems and pressures facing US Health Systems”.
The ABHI US Accelerator Programme is a 12-month programme designed to support UK HealthTech companies access the US healthcare market. The programme provides participants with mentorship and access to a network of industry experts to help them grow and succeed.
The 2023 programme will run from January 2023 – December 2023. A centrepiece of the programme is ABHI’s calendar of trade missions, which take place throughout the year, taking members to key states across the US and providing them with prime opportunities to engage with key stakeholders for their individual company objectives and present proven UK HealthTech to new clients.
The first mission for the new class of ABHI US Accelerator companies will take place in Austin, San Antonio and El Paso, 26 February – 31 March, followed by visits to Tennessee, California, and Florida throughout the remainder of the year.
Paul Benton, Managing Director, International, ABHI commented: “We are delighted that our programme continues to attract such high calibre applicants. The ABHI US Accelerator is an excellent platform for UK HealthTech innovators looking to tap into the US healthcare market. In helping companies to define and de-risk their market entry strategy, it also acts as a catalyst for growth, offering access to senior physicians, c-suite level health system executives, payers and a broad network of US healthcare contacts. We look forward to supporting each company in their individual objectives to grow and succeed within one of the world’s largest HealthTech markets.”
For more information about the ABHI US Accelerator, visit: https://www.abhi.org.uk/international/abhi-us-accelerator/
ABHI is the UK’s leading industry association for health technology (HealthTech). ABHI supports the HealthTech community to save and enhance lives. Members, including both multinationals and small and medium sized enterprises (SMEs), supply products from syringes and wound dressings to surgical robots and digitally enhanced technologies. We represent the industry to stakeholders, such as the government, NHS and regulators. HealthTech plays a key role in supporting delivery of healthcare and is a significant contributor to the UK’s economic growth. HealthTech is the largest employer in the broader Life Sciences sector, employing 145,700 people in 4,300 companies, with a combined turnover of £30bn. The industry has enjoyed growth of around 5% in recent years. ABHI’s 330 members account for approximately 80% of the sector by value.